CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.40
+2.20%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$4.37
From 52W high−50.89%
Volume247596.00
Market cap$66.00M
P/E (TTM)—
P/S (TTM)2.1x
Div yield34.05%
Key dataNov 4, 2026
Open
$4.37
From 52W high
−50.89%
Volume
247596.00
Market cap
$66.00M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−13.1x
P/E (TTM)
—
RSI (14)
33.3
MomentumView details →
1D Return
+2.20%
YTD Return
+5.72%
SummaryUpdated Jun 1, 2026
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a specialty pharmaceutical company founded in 1999 and headquartered in Nashville, Tennessee. The company went public in August 2009 and focuses on acquiring, developing, and commercializing prescription medications primarily for hospital acute care settings. Cumberland has built a portfolio of FDA-approved branded pharmaceutical products while also developing a clinical pipeline of investigational drugs targeting rare diseases and unmet medical needs.
Similar companies
Latest newsMore news →
CUMBERLAND PHARMACEUTICALS INC announced that it will release its third-quarter 2026 financial results after the market closes on November 10, 2026.21h agoCumberland Pharmaceuticals announced top-line results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban in patients with systemic sclerosis, reporting that the drug was well tolerated.12d agoCumberland Pharmaceuticals announced that it will present an update on its ifetroban DMD program on a national call.16d ago